Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Lechleider Robert. Officer active across 1 company, notably Immunome Inc.. Aggregated, 9 filings have been recorded. Split: 1 buy · 5 sells. Total volume traded: €1.2m. History available since 21 November 2024. The latest transaction was filed on 23 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Lechleider Robert is Chief Medical Officer at Immunome Inc. The declarant has 8 filings in total, and the sampled recent filings run from 2024-11-25 to 2026-07-07. In this recent sample, purchases total EUR 142042 and sales EUR 1089349, with Cession as the modal transaction nature.